Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.
about
Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonistsModulation of Ca2+-currents by sequential and simultaneous activation of adenosine A1 and A 2A receptors in striatal projection neurons.Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonismActivation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.A(2A) Receptor Antagonism and Dyskinesia in Parkinson's DiseaseThe role of adenosine in Alzheimer's diseaseMaladaptive Synaptic Plasticity in L-DOPA-Induced DyskinesiaAdenosine A2A antagonists in Parkinson's disease: what's next?A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets.Microfabricated sampling probes for in vivo monitoring of neurotransmitters.Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockadeDopamine-Induced Changes in Gαolf Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian MiceStriatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease.Intracerebral microdialysis of adenosine and adenosine monophosphate - a systematic review and meta-regression analysis of baseline concentrations
P2860
Q28476722-D03EE38F-5B6F-4ABF-B7A9-F0136249219CQ33692607-9BBF0FF6-50A1-45C6-A03B-F47D398CE4CAQ34509861-6A3FB0EC-7316-4ED5-9738-C56E52574094Q34576218-E85E7128-FB7D-4374-AE4B-9C10AE8B50FFQ35070472-80796538-57F8-45FE-AAEA-21914F5C29F0Q35167540-13F4A408-B01E-46E4-B608-E7B534BECA7DQ36057652-136C64F8-1682-4B85-B647-249BA463E684Q37402673-7176FEC9-F9C0-4E72-A908-AF566F12EAF1Q37516434-32C9B5BB-5ADB-46D6-B700-4625929FD85EQ38010070-2493CC96-2160-43E3-AA72-EA7B73A8EB96Q38169996-46CCBD9C-3466-468B-8A7A-45B1410999D6Q38602173-F2CD452A-9EF4-4C71-B721-A18CE2A002CEQ40340800-FE0E0336-ED54-40A8-82DF-8476C322AFDEQ40722338-57250963-93AA-4426-BCA4-7FDB374D1446Q42322627-3828A518-8B5E-4F94-9A5C-B1B569338C95Q47105024-33A6B9B0-83BE-4E8F-8760-7951693061C5Q58697746-972EFBB8-815C-4B2F-9489-F6A1FB172CD6
P2860
Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Modification of adenosine extracellular levels and adenosine A
@nl
Modification of adenosine extr ...... mRNA by dopamine denervation.
@en
type
label
Modification of adenosine extracellular levels and adenosine A
@nl
Modification of adenosine extr ...... mRNA by dopamine denervation.
@en
prefLabel
Modification of adenosine extracellular levels and adenosine A
@nl
Modification of adenosine extr ...... mRNA by dopamine denervation.
@en
P2093
P1476
Modification of adenosine extr ...... r mRNA by dopamine denervation
@en
P2093
Anna Rosa Carta
Claudia Corsi
Felicita Pedata
Valentina Valentini
P356
10.1016/S0014-2999(02)01818-6
P407
P577
2002-06-01T00:00:00Z